VIROMED MEDICAL NA O.N. Tangible Net Worth Ratio
VIROMED MEDICAL NA O.N. tangible net worth ratio. VIROMED MEDICAL NA O.N. (VME) has a Tangible Net Worth Ratio of 99.0% as of December 2025. This metric is calculated by deducting intangible assets (€107.06K) from net assets (€10.47 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore VIROMED MEDICAL NA O.N. equity growth rate to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of VIROMED MEDICAL NA O.N. (2022–2025)
Tangible net worth ratio of VIROMED MEDICAL NA O.N. from 2022 to 2025. This chart shows how VIROMED MEDICAL NA O.N.'s Tangible Net Worth Ratio has changed across 4 annual periods from 2022 to 2025. As of December 2025, the ratio stands at 99.0%, reflecting net assets of €10.47 Million with intangible assets of €107.06K EUR.
VIROMED MEDICAL NA O.N. Tangible Net Worth Ratio by Year (2022–2025)
VIROMED MEDICAL NA O.N. tangible net worth ratio by year from 2022 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for VIROMED MEDICAL NA O.N. from 2022 to 2025, covering 4 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see VIROMED MEDICAL NA O.N. market capitalisation.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 99.0% | €10.47 Million | €107.06K | €13.91 Million | ▲ +8.2 pp |
| 2024 | 90.7% | €9.27 Million | €858.91K | €13.40 Million | ▼ -9.3 pp |
| 2023 | 100.0% | €19.97 Million | €0.00 | €20.33 Million | ▲ +0.0 pp |
| 2022 | 100.0% | €20.08 Million | €0.00 | €20.26 Million | — |